تجاوز إلى المحتوى الرئيسي
drug protocol number
A051301
drug sponsor
SWOG (Southwest Oncology Group)
drug study
Ibrutinib
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh)
drug status
Ongoing
drug phase